Status:
COMPLETED
Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborating Sponsors:
ONS Foundation
Conditions:
Neuropathy
Gastrointestinal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effects on strength, balance, and neuropathic symptoms (numbness, tingling, pain, weakness) of a 12 week, bi-weekly, 60 minute, group exercise program desi...
Eligibility Criteria
Inclusion
- Prior history of colon cancer
- Completed oxaliplatin based chemotherapy at least 6 months prior to enrollment
- Report numbness, tingling, or pain of the lower extremities ≥ 4 by chemotherapy induced peripheral neuropathy (CIPN) Visual Analog Rating
- Karnofsky performance status of at least 60%
- Able to read, write, and understand English
Exclusion
- Patients will be excluded from the study if they live outside of a 30 mile radius of the University of South Florida, if they are currently undergoing chemotherapy or radiation therapy, or if they regularly (at least once a week) participate in strength or balance training exercises. The investigators will not exclude participants if they are participating in aerobic exercise, but we will collect that information so that the investigators may control for aerobic exercise in our data analysis.
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01422993
Start Date
July 1 2011
End Date
December 1 2016
Last Update
December 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States, 33612